Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations
Tejaswini Kulkarni(University of Alabama at Birmingham), Steven R. Duncan(University of Alabama at Birmingham), Sierra C. Simmons(Spectrum Health), Takudzwa Mkorombindo(University of Alabama at Birmingham), Tracy Luckhardt(University of Alabama at Birmingham), Thi K. Tran-Nguyen(University of Alabama at Birmingham), Fei Fei(University of Southern California), Huy P. Pham(National Marrow Donor Program), Luisa D. Quesada-Arias(Brigham and Women's Hospital), Vincent G. Valentine(Ochsner Medical Center), K.G. Dsouza(University of Alabama at Birmingham)
Cited by 19
Related Papers
Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis
|Science Translational Medicine|2013|350
Serpine 1 induces alveolar type <scp>II</scp> cell senescence through activating p53‐p21‐Rb pathway in fibrotic lung disease
|Aging Cell|2017|230
Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis
|The Journal of Immunology|2007|160
Therapeutic Targeting of Src Kinase in Myofibroblast Differentiation and Pulmonary Fibrosis
|Journal of Pharmacology and Experimental Therapeutics|2014|111
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|105